SOPHiA GENETICS
Focus: SOPHiA GENETICS operates a clinical next-generation sequencing (NGS) dry lab service focused on oncology, providing analytical interpretation of genetic data to support patient care and clinical trials. The company is positioned as a specialized biotech service provider in the growing precision oncology diagnostics market.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Open Jobs
1
Should You Work at SOPHiA GENETICS?
AI assessmentBest suited for professionals seeking specialized NGS analytics or commercial diagnostic roles in precision oncology; not ideal for drug development or large-scale career progression.
Why Work Here
- Growing precision oncology market with direct clinical impact—NGS dry lab services are increasingly critical to treatment decisions as genomic medicine expands.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MR-elastography exam
Kidney CancerClinical Trials (1)
NCT06525831Rein 3D PRINT MECHANICS
N/AHelp build intelligence for SOPHiA GENETICS
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.